BioAdaptives, Inc. (BDPT) stock
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
BioAdaptives revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
BioAdaptives's revenue for the twelve months ending Jun 30, 2026 was $25.56K, up 694.1% year over year. For fiscal 2025 it was $18.28K, up 44.3% from the year before. The highest annual figure on record is $28.57K in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.28K | +44.3% |
| FY2024 | Dec 31, 2024 | $12.67K | -55.6% |
| FY2023 | Dec 31, 2023 | $28.57K | +66.3% |
| FY2022 | Dec 31, 2022 | $17.18K | -13.1% |
| FY2021 | Dec 31, 2021 | $19.78K | +21.1% |
| FY2020 | Dec 31, 2020 | $16.33K | +64.4% |
| FY2019 | Dec 31, 2019 | $9.93K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.99K | +55.0% |
| Q1 FY2026 | Mar 31, 2026 | $5.51K | – |
| Q4 FY2025 | Dec 31, 2025 | $10.43K | – |
| Q3 FY2025 | Sep 30, 2025 | $4.63K | – |
| Q2 FY2025 | Jun 30, 2025 | $3.22K | +376.9% |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $675 | -71.1% |
| Q1 FY2024 | Mar 31, 2024 | $11.99K | +255.3% |
| Q4 FY2023 | Dec 31, 2023 | $7.20K | +80.7% |
| Q3 FY2023 | Sep 30, 2023 | $15.65K | +369.0% |
| Q2 FY2023 | Jun 30, 2023 | $2.34K | -45.9% |
| Q1 FY2023 | Mar 31, 2023 | $3.38K | -39.0% |
| Q4 FY2022 | Dec 31, 2022 | $3.98K | +3.5% |
| Q3 FY2022 | Sep 30, 2022 | $3.34K | -37.5% |
| Q2 FY2022 | Jun 30, 2022 | $4.32K | -28.7% |
| Q1 FY2022 | Mar 31, 2022 | $5.53K | +22.5% |
| Q4 FY2021 | Dec 31, 2021 | $3.85K | +3.2% |
| Q3 FY2021 | Sep 30, 2021 | $5.34K | +20.3% |
| Q2 FY2021 | Jun 30, 2021 | $6.07K | +73.2% |
| Q1 FY2021 | Mar 31, 2021 | $4.52K | -2.9% |
| Q4 FY2020 | Dec 31, 2020 | $3.73K | +223.0% |
| Q3 FY2020 | Sep 30, 2020 | $4.44K | +113.8% |
| Q2 FY2020 | Jun 30, 2020 | $3.50K | -32.3% |
| Q1 FY2020 | Mar 31, 2020 | $4.66K | +203.9% |
| Q4 FY2019 | Dec 31, 2019 | $1.16K | -90.3% |
| Q3 FY2019 | Sep 30, 2019 | $2.08K | – |
| Q2 FY2019 | Jun 30, 2019 | $5.17K | – |
| Q1 FY2019 | Mar 31, 2019 | $1.53K | – |
| Q3 FY2016 | Sep 30, 2016 | $11.94K | – |
See a number that looks wrong?